1 / 41

Myelination in Pediatric Neurology

Myelination in Pediatric Neurology. Robert Carson MD PhD Pediatric Neurology Resident L ecture Series DOT 8155 09.13.2013. Goals. Review development of Myelin Discuss Normal Myelin Imaging Outline an approach to Leukodystrophies. What we will not discuss today. ADEM MS

Download Presentation

Myelination in Pediatric Neurology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Myelination in Pediatric Neurology Robert Carson MD PhD Pediatric Neurology Resident Lecture Series DOT 8155 09.13.2013

  2. Goals • Review development of Myelin • Discuss Normal Myelin Imaging • Outline an approach to Leukodystrophies

  3. What we will not discuss today • ADEM • MS • Primary inflammatory disorders of CNS • Myelin basic science (2 weeks) • My groundbreaking research in exquisite detail :^(

  4. White matter in neurodevelopment. • Abnormal connectivity may contribute to neurocognitive deficits in: • Autism • TSC • Angelman’s • Periventricular leukomalacia (spike-timing dependent plasticity) (Nave, K. 2010)

  5. Timing of myelination mirrors human development

  6. Cortical thickness reaches a developmental nadir while myelin continues to increase

  7. Normal myelination/general MRI patterns • Need to know what is normal to know what is not normal. • Neonate: T1 hypo T2 hyper • Fully myelinated: T1 hyper T2 hypo • T1 signal increases with increasing cholesterol and galactocerebroside • T2 signal decreases with decreasing amount of brain water • displaced by myelin • Increased length hydrocarbons and double bonds • T2 changes lag behind T1 changes

  8. General Patterns of myelination • Rostral to caudal • Posterior to anterior • Central to peripheral

  9. T1 T1 T2 FLAIR

  10. T1 FLAIR T2-FSE T2-FSE

  11. T1 FLAIR T2-FSE T2-FSE

  12. T1 FLAIR T2-FSE T2-FSE

  13. FLAIR FLAIR T2-FSE T2-FSE

  14. Normal Variant FLAIR FLAIR T2-FSE T2-FSE

  15. FLAIR Signal evolution

  16. 9m 15m 2y 3y

  17. Terminal Zones of myelination

  18. Components of myelin: • Sheath: protein-lipid-protein-lipid-protein • Glycolipids: glalctocerebroside, sulfatide, cholesterol • Outer layer of membrane • Long chain fatty acids (middle) • Phospholipids: • Hydrophobic, on inner membrane • Others: MAG, MOG, PLP, MBP, CNPase

  19. Leukodystrophies • Genetic, with degeneration of myelin sheaths in CNS (+/-) PNS • Related to synthesis and maintenance of myelin membranes. • Vast majority autosomal recessive • Leukoencephalopathies: defects causing secondary myelin damage • Diagnosis requires a clinical strategy

  20. Clinical presentation • Insiduous, in a previously healthy child. • Slowly progressing, may have periods of stagnation • Vague/progressive motor and mental symptoms. • Widely variable phenotypes associated with single genetic disease • Presents from infancy to adulthood.

  21. Age of onset

  22. Exam • Physical abnormalities uncommon • Big head: Alexander, Canavan, megalencephalicleukodystrophy with cysts and vanishing white matter • Dysmorphic features similar to mucopolysacharidoses: fucosidosis, MLD • Neurologic (progressive): • Motor (spasticity) • Changes in cognition and language • Seizures are rare • Peripheral nerve (MLD, globoid cell, hypomyelination)

  23. Diagnosis: MRI most important test • Stepwise approach: • Hypomyelination? • Differentiate delayed vs. permanent with serial MRI studies • Confluent, bilateral, symmetric wm lesions c/w genetic disease vs. multifocal or asymmetric with acquired disease • If confluent lesions are present, what is the localization? (frontal, parieto-occiptial, periventricular, subcortical, diffuse, posterior fossa)

  24. Abnormal MRIs are not pathognomonic • Tigroid appearance • MLD • Globiod cell • Sparing of U-fibers • X-ALD • MLD

  25. “Nearly pathognomonic” • Alexander disease

  26. Contrast enhancement if an inflammatory component

  27. FLAIR good for cysts

  28. Additional imaging • MRS • NAA elevated in Canavan • Decreased NAA suggests neuronal involvement in primary WM disease • Lactate in “leukencephalopathy with brainstem and spinal cord involvement and elevated lactate” • Other mitochondrial disorders • CT: better than MRI for calcifications

  29. Globoid cell leukodystrophy • Swelling of optic nerves • Contrast enhancement of spinal roots • +/- peripheral nerve thickening

  30. Electrophysiology • NCS • Symmetric involvement of long spinal tracks and peripheral nerves • May help differentiate leukodystrophies • Normal in X-ALD, usually abnormal with metachromatic or globoid cell • Correlates with severity of clinical disease • Evoked potentials • BAER abnormal first, then SSEP lower limbs, then MEPs of lower limbs

  31. Tests to consider early on in evaluation. • Low yield of done prior to exam and evaluation of imaging.

  32. Other organ systems • Optho • Cataracts • Cerebrotendinousxanthomatosis • Some forms of hypomyelination • Cherry red spot: differentiate infantile/macrocephalicleukodystrophies from GM2 gangliosidosis • Such as Tay-Sachs and Sandhoff • Endocrine • Addison’s disease +/- neuroinvovlement in X-ALD • Ovarian failure • GI • Feeding and swallow issues are common. • Gallbladder papilloma in MLD

  33. Treatment • Prognosis is dismal • Supportive care • Swallow eval/g-tube • Abx when indicated • Antispasmodics and pain control. • ACTH monitoring/stress dose steroids

  34. Treatment Continued • Lorenzo’s oil in X-ALD • Erucic and oleic acid • Lowers VLC FAs • Benefits asymptomatic boys • Bone Marrow transplantation • Can halt progression in X-ALD, but… • 2/3 boys develop cerebral disease, and… • Successful only in early stages of disease. • Gene therapy • Experimental • Therapeutic window is narrow • Asymptomatic____  Too far gone

  35. Leukodystrophies, in Summary: • Incurable with progressive motor and mental disability • Leukodystrophy if due to myelin sheath, leukoencephalopathy if outside. (similar) • White matter and gray matter disease may overlap. • Definitive diagnosis is challenging, though timely diagnosis is required.

  36. Summary continued, • Diagnosis through: • Physical examination • MRI imaging • With help from targeted laboratory testing • Important for family counseling and optimization of care • Palliative • experimental

  37. References • Welker and Patton. Assessment of normal myelination with magnetic resonance imaging. Semin Neurol. 2012;32:15-28. • Kohlshutter and Eichler. Childhood leukodystrophies: a clinical perspective. Expert Rev. Neurother. 2011;11:1485-1496.

More Related